Vertex Pharma slides 12% after deciding not to advance VX-864 into late-stage development; Dave & Busters jumps over 3% on earnings beat Check out this evening's top movers from around Wall Street, compiled by The Fly.
UP AFTER EARNINGS
- Dave & Busters (PLAY) up 3.5%
ALSO HIGHER
- Precigen (PGEN) up 30.2% after its Phase 1b/2a study of AG019 ActoBiotics met primary endpoints
- Apollo Medical (AMEH) up 10.5% after entering S&P SmallCap 600 index
- Gilead (GILD) up 0.6% after FDA approved its expansion of the pediatric indication of Epclusa in HCV
DOWN AFTER EARNINGS
- Navigator Holdings (NVGS) down 1.1%
- Chewy (CHWY) down 1.0%
ALSO LOWER
- Vertex Pharma (VRTX) down 12.7% after announcing it will not advance VX-864 into late-stage development following Phase 2 study data
- Callaway Golf (ELY) down 4.5% after entering S&P MidCap 400 index
- Agree Realty (ADC) down 3.2% after equity offering
- Jiayin Group (JFIN) down 2.7% after equity offering
Symbols:
PLAY PGEN AMEH GILD NVGS CHWY VRTX ELY ADC JFIN Keywords: fly intel, wall street, afterhours, movers, top stories, stocks, Chewy, Vertex Pharmaceuticals